Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 245219)

Published in Antimicrob Agents Chemother on August 01, 1991

Authors

E Heikkilä1, L Sundström, M Skurnik, P Huovinen

Author Affiliations

1: Department of Medical Microbiology, Turku University, Finland.

Articles citing this

Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother (1995) 3.19

IntI2 integron integrase in Tn7. J Bacteriol (2002) 1.95

Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. J Clin Microbiol (1998) 1.40

Characterization of transposon Tn5086, carrying the site-specifically inserted gene dhfrVII mediating trimethoprim resistance. J Bacteriol (1993) 1.35

Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol (2008) 1.10

New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron. Antimicrob Agents Chemother (2000) 0.97

Spread of a newly found trimethoprim resistance gene, dhfrIX, among porcine isolates and human pathogens. Antimicrob Agents Chemother (1992) 0.97

Multiple-drug resistance in D-tartrate-positive Salmonella enterica serovar paratyphi B isolates from poultry is mediated by class 2 integrons inserted into the bacterial chromosome. Antimicrob Agents Chemother (2003) 0.92

Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob Agents Chemother (1995) 0.88

Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element. PLoS One (2012) 0.88

Sequence identity with type VIII and association with IS176 of type IIIc dihydrofolate reductase from Shigella sonnei. Antimicrob Agents Chemother (1995) 0.86

Prevalence and genetic location of non-transferable trimethoprim resistant dihydrofolate reductase genes in South African commensal faecal isolates. Epidemiol Infect (1995) 0.83

The distribution of the DHFR genes in trimethoprim-resistant urinary tract isolates from Taiwan. Epidemiol Infect (1992) 0.81

Articles cited by this

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01

The integrase family of site-specific recombinases: regional similarities and global diversity. EMBO J (1986) 8.12

Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J Bacteriol (1976) 4.88

Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. Mol Gen Genet (1988) 4.63

The region of the IncN plasmid R46 coding for resistance to beta-lactam antibiotics, streptomycin/spectinomycin and sulphonamides is closely related to antibiotic resistance segments found in IncW plasmids and in Tn21-like transposons. Nucleic Acids Res (1987) 3.54

Unique insertion site of Tn7 in the E. coli chromosome. Nature (1982) 2.65

Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3"(9)-O-nucleotidyltransferase. Nucleic Acids Res (1985) 2.33

The nucleotide sequence of the trimethoprim-resistant dihydrofolate reductase gene harbored by Tn7. Nucleic Acids Res (1983) 2.28

Homology of ORFs from Tn2603 and from R46 to site-specific recombinases. Nucleic Acids Res (1987) 2.18

Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases. J Bacteriol (1983) 2.15

Analysis of Tn7 transposition. Mol Gen Genet (1986) 2.08

The nucleotide sequence of the tnpA gene of Tn21. Nucleic Acids Res (1987) 1.86

A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R factor mediating high resistance to trimethoprim. J Biol Chem (1974) 1.74

Relationships among the streptothricin resistance transposons Tn1825 and Tn1826 and the trimethoprim resistance transposon Tn7. Plasmid (1987) 1.74

Insertions of resistance genes into Tn21-like transposons. J Antimicrob Chemother (1986) 1.70

Monitoring of plasmid-encoded, trimethoprim-resistant dihydrofolate reductase genes: detection of a new resistant enzyme. Antimicrob Agents Chemother (1982) 1.67

Genetic and physical map of plasmid NR1: comparison with other IncFII antibiotic resistance plasmids. Microbiol Rev (1988) 1.65

Trimethoprim resistance. Antimicrob Agents Chemother (1987) 1.62

DNA sequence analysis of five genes; tnsA, B, C, D and E, required for Tn7 transposition. Nucleic Acids Res (1990) 1.54

Tn7 transposition: recognition of the attTn7 target sequence. Proc Natl Acad Sci U S A (1989) 1.52

Novel type of plasmid-borne resistance to trimethoprim. Antimicrob Agents Chemother (1987) 1.46

Bacterial transposon Tn7 utilizes two different classes of target sites. J Bacteriol (1990) 1.36

Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29

Two naturally occurring transposons indistinguishable from Tn7. J Gen Microbiol (1977) 1.20

A clinical isolate of Escherichia coli owing its trimethoprim resistance to a chromosomally-located trimethoprim transposon. J Antimicrob Chemother (1981) 1.15

Increasing importance of plasmid-mediated trimethoprim resistance in enterobacteria: two six-month clinical surveys. Br Med J (1980) 1.08

Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis (1989) 1.06

Distribution and genetic location of Tn7 in trimethoprim-resistant Escherichia coli. J Med Microbiol (1986) 1.05

Transposons encoding trimethoprim or gentamicin resistance in medically important bacteria. Cold Spring Harb Symp Quant Biol (1981) 1.04

Plasmid-borne or chromosomally mediated resistance by Tn7 is the most common response to ubiquitous use of trimethoprim. Antimicrob Agents Chemother (1985) 1.04

R plasmid dihydrofolate reductase with a dimeric subunit structure. J Biol Chem (1983) 1.04

Trimethoprim resistance amongst urinary pathogens in south India. J Antimicrob Chemother (1986) 1.01

The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother (1990) 1.01

Trimethoprim resistance in Escherichia coli isolates from a geriatric unit. Antimicrob Agents Chemother (1990) 0.89

Trimethoprim resistance in urinary coliforms from patients in the community: plasmids and R-transfer. J Antimicrob Chemother (1985) 0.87

Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae. Eur J Clin Microbiol (1986) 0.82

Transferable resistance plasmids as a contributory cause of increasing trimethoprim resistance in general practice. J Antimicrob Chemother (1983) 0.80

Articles by these authors

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83

Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol (1996) 4.49

Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature (1988) 4.20

Antimicrobial resistance. Is a major threat to public health. BMJ (1998) 4.18

A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97

The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother (1993) 3.80

Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol (1992) 3.62

The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol Microbiol (1991) 3.56

Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother (1995) 3.19

Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02

Virulence plasmid-associated autoagglutination in Yersinia spp. J Bacteriol (1984) 3.01

Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J Bacteriol (1994) 2.97

Plasmids in Yersinia enterocolitica serotypes O:3 and O:9: correlation with epithelial cell adherence in vitro. Infect Immun (1981) 2.85

Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother (1999) 2.73

Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol (1993) 2.41

Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun (1987) 2.40

Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36

Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33

Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33

Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis. Arthritis Rheum (1991) 2.18

Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13

Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis (1995) 2.07

YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol (2001) 2.00

The lcrE gene is part of an operon in the lcr region of Yersinia enterocolitica O:3. J Bacteriol (1990) 1.94

Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun (1988) 1.90

Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol (2000) 1.83

katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother (1996) 1.82

Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78

Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75

Non-palindromic attl sites of integrons are capable of site-specific recombination with one another and with secondary targets. Mol Microbiol (1997) 1.68

Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66

Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet (1990) 1.65

Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions. Infect Immun (1985) 1.64

Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63

Genetic organization and sequence of the rfb gene cluster of Yersinia enterocolitica serotype O:3: similarities to the dTDP-L-rhamnose biosynthesis pathway of Salmonella and to the bacterial polysaccharide transport systems. Mol Microbiol (1993) 1.62

Molecular and chemical characterization of the lipopolysaccharide O-antigen and its role in the virulence of Yersinia enterocolitica serotype O:8. Mol Microbiol (1997) 1.62

Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding. Mol Microbiol (2000) 1.55

A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element. Antimicrob Agents Chemother (1993) 1.51

Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis (1997) 1.50

Lack of correlation between the presence of plasmids and fimbriae in Yersinia enterocolitica and Yersinia pseudotuberculosis. J Appl Bacteriol (1984) 1.49

Control of antimicrobial resistance: time for action. The essentials of control are already well known. BMJ (1998) 1.48

Antibiotic resistance. How wild are wild mammals? Nature (2001) 1.48

Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br J Obstet Gynaecol (1996) 1.48

Guideline for the management of acute sore throat. Clin Microbiol Infect (2012) 1.48

Novel type of plasmid-borne resistance to trimethoprim. Antimicrob Agents Chemother (1987) 1.46

Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis (1995) 1.43

In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria. Antimicrob Agents Chemother (1987) 1.41

Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect (2005) 1.39

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis (1998) 1.36

Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother (1993) 1.34

A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33

A synthetic oligonucleotide probe and a cloned polynucleotide probe based on the yopA gene for detection and enumeration of virulent Yersinia enterocolitica. Appl Environ Microbiol (1990) 1.33

Complete genomic sequence of the lytic bacteriophage phiYeO3-12 of Yersinia enterocolitica serotype O:3. J Bacteriol (2001) 1.30

Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29

Simultaneous real-time PCR detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis. Eur J Clin Microbiol Infect Dis (2007) 1.27

Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol (1991) 1.27

In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother (2001) 1.27

Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother (1999) 1.24

Transposon targeting determined by resolvase. FEMS Microbiol Lett (2000) 1.24

Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22

Expression cloning of Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb Pathog (1991) 1.21

Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec (2004) 1.21

Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia (2011) 1.20

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis (1990) 1.20

Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother (1992) 1.20

Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19

Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum (1992) 1.19

Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group. J Antimicrob Chemother (2000) 1.19

Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect Immun (1992) 1.18

Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun (1991) 1.18

Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables. J Antimicrob Chemother (1999) 1.17

Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br Med J (1980) 1.16

Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis (1992) 1.14

The effect of growth temperature on the biosynthesis of Yersinia enterocolitica O:3 lipopolysaccharide: temperature regulates the transcription of the rfb but not of the rfa region. Microb Pathog (1991) 1.13

Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol (2000) 1.12

Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10

Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1993) 1.10

Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun (1995) 1.09

Role of the Yersinia outer membrane protein YadA in adhesion to rabbit intestinal tissue and rabbit intestinal brush border membrane vesicles. APMIS (1991) 1.07

Functional expression of adhesive peptides as fusions to Escherichia coli flagellin. Protein Eng (1997) 1.07

Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis (1998) 1.07

In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother (1993) 1.06

Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05

Bacteriotherapy: the time has come. BMJ (2001) 1.03

Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis (1994) 1.03

Genetic evidence that the yopA gene-encoded Yersinia outer membrane protein Yop1 mediates inhibition of the anti-invasive effect of interferon. Infect Immun (1990) 1.02

The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother (1990) 1.01

Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun (1994) 1.01

Experimental intestinal infection of rats by Yersinia enterocolitica 0:3. A follow-up study with specific antibodies to the virulence plasmid specified antigens. Scand J Infect Dis (1986) 1.00

Construction of urease-negative mutants of Yersinia enterocolitica serotypes O:3 and o:8: role of urease in virulence and arthritogenicity. Infect Immun (2000) 1.00

Dental amalgam fillings and the amount of organic mercury in human saliva. Caries Res (2001) 0.99

Erythromycin resistance in group A streptococci. Lancet (1989) 0.99